Subcutaneous ICD treats fibrillation as effectively as traditional devices - studies
This article was originally published in Clinica
Executive Summary
Cameron Health's entirely subcutaneous implantable cardioverter-defibrillator (ICD) – said to be the first of its kind – can detect and treat ventricular fibrillation, two trials have shown. The lead UK investigator of the two company-sponsored trials, Dr Andrew Grace, of the University of Cambridge, called the S-ICD an "enormous" leap forward compared to conventional devices.